Reconsidering Prostate Cancer Mortality — The Future of PSA Screening
H. Gilbert Welch, Peter C. Albertsen
Abstract
Since PSA screening and the treatment that may follow result in trading off one cause of death for another, rather than extending life, providers who support such screening should offer patients a better deal by protecting them from overdiagnosis and overtreatment.
Topics & Concepts
OverdiagnosisMedicineProstate cancerProstate cancer screeningIntensive care medicineCancerCause of deathCancer screeningGynecologyProstate-specific antigenInternal medicineDiseaseProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchColorectal Cancer Screening and Detection